Skip to main content
. 2022 Aug 29;6(3):83–97. doi: 10.1159/000525897

Table 2.

Data standards for regulatory submissions of BioMeTs

Standard name Format Focus
CDISC Tabulation data: Objective: regulatory submission of clinical trial data
− The Study Data Tabulation Model (SDTM) including (SDTMIG-MD for medical devices collected data) Note: additional metadata collected from medical devices is required with respect to data collected from BioMeTs (e.g., the location where the device was used) (Badawy et al. [64])
− Standard Exchange for Nonclinical Data (SEND) Geographic scope:
Analysis data: − Recommended by FDA and Japan PMDA for regulatory submissions
− Analysis Data Model (ADaM) − Preferred by China NMPA
− Endorsed by EMA

Open mHealth Open Mobile Health Objective: Mobile health data interoperability standard for patient health generated data